Clinical Trial Update: The Effect Of Fesoterodine On Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating whether fesoterodine affects the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Toviaz (fesoterodine fumarate)
• Warfarin (warfarin)

Snippet

Sponsor: Pfizer | Conditions: Urinary Bladder, Overactive | Phase 1 | Status: COMPLETED